Trisalus Lf Sc Cm A (TLSI)
$3.70 -4.15% Close Oct 30, 2026 Live
Trisalus Lf Sc Cm A stock today
Trisalus Lf Sc Cm A closed at $3.70 on October 30, 2026, down 4.15% on the day. Over the past year it returned -20.8% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $227 million.
$4.00$6.00
NovJan 2026MarMayJulSep
| Period | TLSI | S&P 500 (SPY) |
|---|---|---|
| 1 month | -14.2% | -0.9% |
| 3 months | -18.9% | +2.1% |
| Year to date | -47.0% | +11.7% |
| 1 year | -20.8% | +12.4% |
| 3 years | -19.6% | +88.5% |
Key statistics
- Market value
- $227M
- Price / sales
- 5.0
- 52-week range
- $2.52 to $7.50
- Next report
- Nov 10, 2026
About Trisalus Lf Sc Cm A
Develops immunotherapy and cell therapy treatments for cancer.
Sector: Health Care
More on Trisalus Lf Sc Cm A
- Financials: revenue, earnings and segmentsRevenue +53% in the year to Dec 2025
- Returns: what $1,000 became$1,000 three years ago is $804.35 today
No forecast, no recommendation. This page describes Trisalus Lf Sc Cm A from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.